Cpt1aem1Fink
Endonuclease-mediated Allele Detail
|
Symbol: |
Cpt1aem1Fink |
Name: |
carnitine palmitoyltransferase 1a, liver; endonuclease-mediated mutation 1, Toren Finkel |
MGI ID: |
MGI:6470470 |
Synonyms: |
Cpt1afl |
Gene: |
Cpt1a Location: Chr19:3372334-3435733 bp, + strand Genetic Position: Chr19, 3.08 cM
|
Alliance: |
Cpt1aem1Fink page
|
|
Strain of Origin: |
(C57BL/6N-Atm1Brd x C57BL/6J)F1
|
|
Allele Type: |
|
Endonuclease-mediated (Conditional ready) |
Mutation: |
|
Insertion
|
|
|
Mutation details: Theoriginal targeting construct is composed of an FRT site followed by a lacZ sequence and a loxP site inserted upstream of exon 4. This first loxP site was followed by neomycin under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site was inserted downstream of exon 4. The construct, clone HEPD0727_3_A09, was introduced into C57BL/6N-Atm1Brd-derived JM8A3.N1 embryonic stem (ES) cells. Flp-mediated recombination removed the FRT-flanked lacZ and neo cassette. It was then determined that the third loxP site was absent and the ES cell line was retargeted using CRISPR/Cas9 genome editing to insert a loxP site downstream of exon 4.
(J:270066)
|
|
|
|
Original: |
J:270066 Nomura M, et al., Macrophage fatty acid oxidation inhibits atherosclerosis progression. J Mol Cell Cardiol. 2019 Jan 9;127:270-276 |
All: |
2 reference(s) |
|